title: Granulocytes UPN184

description: Hybridized to 250K_Nsp

value: granulocytes

value: essential thrombocythemia


title: Granulocytes UPN181

status: Public on Oct 01 2009

type: genomic

city: Ulm

first: Frank

last: Stegelmann

address: Albert-Einstein-Allee 23

department: Internal Medicine III

country: Germany

institute: University Hospital of Ulm

description: Hybridized to 250K_Nsp

hyb_protocol: DNA was restriction digested, PCR amplified, fragmented, labeled and hybridized to each array according to the manufacturer's instructions.

scan_protocol: The Arrays were then washed using Affymetrix fluidics stations, and scanned using the Gene Chip Scanner 3000.

data_processing: CEL files and CHP files (generated by Affymetrix GTYPE) were processed by Copy Number Analyzer for GeneChip (CNAG) version 2.0 software. Normalization was performed against an own set of 30 Sty and 30 Nsp reference samples, respectively. In one case (UPN23) dermal cells were used for paired tumor-germline analysis (UPN23_2).

label: Biotin

molecule: genomic DNA

organism: Homo sapiens

source_name: peripheral blood

label_protocol: As per manufacturer (Affymetrix)

extract_protocol: Genomic DNA was extracted from granulocyte preparations obtained from peripheral blood using DNAzol reagent. DNA quality and quantity was assessed using a Nanodrop Spectrophotometer.

tag: cell type

tag: diagnosis


title: Klf4+72h_rep2

type: RNA

city: Baltimore

first: Minoru

last: Ko

state: MD

address: 251 Bayview Blvd, Suite 100, 10C

department: National Institute on Aging

country: USA

institute: NIH

hyb_protocol: Slides were hybridized according to manufacturers protocol (Two-Color Microarray-Based Genr Expression Analysis Protocol,  Product # G4140-90050, Version 5.0.1, August 2006)

scan_protocol: Slides were scanned with an Agilent DNA Microarray Scanner (model G2505-64120) at 100% and 10% PMT in both channels, with a scan resolution of 5um.

data_processing:
Data are extracted with Agilent Feature Extraction Software.The data were further processed with NIA ANOVA tool utilities.See http://lgsun.grc.nia.nih.gov/ANOVA for details.
The data is normalized with the following method:
(1) Take values from the columns gDyeNormSignal,rDyeNormSignal in the raw files and log-transform them using: log10(max(x,1)). These values will be referenced below as Xgi and Xri where i is array number.
(2) Take average of Xri's for the oligo among 124 arrays in the series:  AverXr = average(Xri).
(3) For each array estimate Yi = Xgi-Xri+AverXr
(4) Round Yi to 4 decimal digits. This is used as the normalized VALUE.
More detailed information with error correction can be found at http://lgsun.grc.nia.nih.gov/ANOVA/help.html#arrayjoin

molecule: total RNA

organism: Mus musculus

source_name: Klf4, +Dox, 72h

label_protocol: Total RNA was labeled using Agilents Low RNA Input Fluorescent Linear Amplification kit, according to manufacturers instructions.

extract_protocol: The samples were dissolved in the well with TRIzol reagent 1/2 mL. They were then transferred to Phase Lock Gel Heavy tubes (eppendorf) and 0.2 volumes of chloroform (Sigma-Aldrich) was added to each sample. They were mixed by hand and allowed to stand for 2-5 min at room temperature. The samples were then separated by centrifugation for 5 minutes at 15,300 rpm on an eppendorf centrifuge at 4C. The aqeous phase was transferred to another eppendorf tube, and 0.8 volumes of ice-cold isopropanol was added. They were allowed to incubate for a minimum of 10 minutes at room temperature. If longer, they were placed at 4C. The sample was centrifuged again at the same conditions for 15 minutes. After centrifugation, the liquid was dumped out of the tubes and the pellet was washed with 1 mL of ice-cold 70% ethanol. The tube was spun for 5 minutes, then the ethanol was dumped out. Excess was removed with a pipette and the pellet was allowed to air dry until no liquid remained, but no longer. ddH2O was then added in the appropriate volume, the sample was allowed to dissolve for 5 minutes at 55C and then transferred to -80C for storage.

treatment_protocol: Day 3: Cells were plated in regular ES medium with Doxycycline (0.2ug/ml) and Puromycin (1.5ug/ml). Approximately 18 hours after plating, the cells were rinsed once with PBS, then the medium was replaced with warmed medium with Doxycycline. Three hours after the first medium change, the medium was changed again. Finally, at three hours after the second medium change, the medium was replaced for a final time.  Thereafter, the medium was changed daily.  At 72 hours after the final wash, the cells were harvested in Trizol. There was no medium change on the day of RNA harvest.

value: Embryonic Stem Cells

tag: strain

tag: gender

value: male

tag: development stage

value: embryo

tag: individual identifier 1

value: Klf4 clone16, Dox+, 72h #3

tag: individual identifier 2

tag: individual identifier 3

source_name: Universal Mouse Reference 129ES Cell

extract_protocol: Total RNA was extracted from cultured cells using a Stratagene Absolutely RNA kit. DNase-treated total RNA samples from 11 cultured cell lines derived from embryo, embryo fibroblast, kidney, liver/hepatocyte, lung/alveolar macrophage, B-lymphocyte, T-lymphocyte (thymus), mammary gland, muscle myoblast, skin, and testis were pooled in equal parts. The resulting URM RNA was mixed with 129ES cell RNA (Lif+) at 2:1 ratio and 2.5ug of mixed RNA was used for labeling in each tube.

tag: cell line

value: mixed


title: Cdx2+48h_rep2

source_name: Cdx2, +Dox, 48h

treatment_protocol: Day 2: Cells were plated in regular ES medium with Doxycycline (0.2ug/ml) and Puromycin (1.5ug/ml). Approximately 18 hours after plating, the cells were rinsed once with PBS, then the medium was replaced with warmed medium with Doxycycline. Three hours after the first medium change, the medium was changed again. Finally, at three hours after the second medium change, the medium was replaced for a final time.  Thereafter, the medium was changed daily.  At 48 hours after the final wash, the cells were harvested in Trizol. There was no medium change on the day of RNA harvest.

value: Cdx2 clone6, Dox+, 48h #3


title: Klf4-24h_rep2

source_name: Klf4, -Dox, 24h

treatment_protocol: Day 1: Cells were plated in regular ES medium with Doxycycline (0.2ug/ml) and Puromycin (1.5ug/ml). Approximately 18 hours after plating, the cells were rinsed once with PBS, then the medium was replaced with warmed medium without Doxycycline. Three hours after the first medium change, the medium was changed again. Finally, at three hours after the second medium change, the medium was replaced for a final time. At 24 hours after the final wash, the cells were harvested in Trizol. There was no medium change on the day of RNA harvest.

value: Klf4 clone16, Dox-, 24h #2


title: Cdx2-48h_rep2

source_name: Cdx2, -Dox, 48h

treatment_protocol: Day 2: Cells were plated in regular ES medium with Doxycycline (0.2ug/ml) and Puromycin (1.5ug/ml). Approximately 18 hours after plating, the cells were rinsed once with PBS, then the medium was replaced with warmed medium without Doxycycline. Three hours after the first medium change, the medium was changed again. Finally, at three hours after the second medium change, the medium was replaced for a final time.  Thereafter, the medium was changed daily.  At 48 hours after the final wash, the cells were harvested in Trizol. There was no medium change on the day of RNA harvest.

value: Cdx2 clone6, Dox-, 48h #4


title: Sox2-72h_rep1

source_name: Sox2, -Dox, 72h

treatment_protocol: Day 3: Cells were plated in regular ES medium with Doxycycline (0.2ug/ml) and Puromycin (1.5ug/ml). Approximately 18 hours after plating, the cells were rinsed once with PBS, then the medium was replaced with warmed medium without Doxycycline. Three hours after the first medium change, the medium was changed again. Finally, at three hours after the second medium change, the medium was replaced for a final time.  Thereafter, the medium was changed daily.  At 72 hours after the final wash, the cells were harvested in Trizol. There was no medium change on the day of RNA harvest.

value: Sox2 clone3, Dox-, 72h #1


title: Sox2-72h_rep2

value: Sox2 clone3, Dox-, 72h #2


title: Sox2+72h_rep2

source_name: Sox2, +Dox, 72h

value: Sox2 clone3, Dox+, 72h #2


title: Klf4+48h_rep1

source_name: Klf4, +Dox, 48h

value: Klf4 clone16, Dox+, 48h #1


title: Granulocytes UPN183

description: Hybridized to 250K_Nsp


title: Granulocytes UPN182

description: Hybridized to 250K_Nsp


title: Sox2+72h_rep1

value: Sox2 clone3, Dox+, 72h #1


title: Granulocytes UPN179

description: Hybridized to 250K_Nsp


title: Granulocytes UPN178

description: Hybridized to 250K_Nsp


title: Granulocytes UPN180

description: Hybridized to 250K_Nsp


title: Pou5f1-72h_rep2

source_name: Pou5f1, -Dox, 72h

value: Pou5f1 clone18, Dox-, 72h #2


title: Pou5f1+72h_rep2

source_name: Pou5f1, +Dox, 72h

value: Pou5f1 clone18, Dox+, 72h #2


title: T-72h_rep2

source_name: T, -Dox, 72h

value: Brachyury (T) clone21, Dox-, 72h #3


title: Pou5f1-72h_rep1

value: Pou5f1 clone18, Dox-, 72h #1


title: Klf4+24h_rep2

source_name: Klf4, +Dox, 24h

treatment_protocol: Day 1: Cells were plated in regular ES medium with Doxycycline (0.2ug/ml) and Puromycin (1.5ug/ml). Approximately 18 hours after plating, the cells were rinsed once with PBS, then the medium was replaced with warmed medium with Doxycycline. Three hours after the first medium change, the medium was changed again. Finally, at three hours after the second medium change, the medium was replaced for a final time.  At 24 hours after the final wash, the cells were harvested in Trizol. There was no medium change on the day of RNA harvest.

value: Embryonic Stem Cells

value: Klf4 clone16, Dox+, 24h #2


title: Pou5f1+72h_rep1

value: male

value: embryo

value: Pou5f1 clone18, Dox+, 72h #1


title: T+72h_rep2

source_name: T, +Dox, 72h

value: Brachyury (T) clone21, Dox+, 72h #3

value: mixed


title: T-72h_rep1

value: Brachyury (T) clone21, Dox-, 72h #2


title: T+72h_rep1

value: Brachyury (T) clone21, Dox+, 72h #1


title: Granulocytes UPN173

description: Hybridized to 250K_Nsp

value: granulocytes

value: essential thrombocythemia


title: Granulocytes UPN174

description: Hybridized to 250K_Nsp


title: Granulocytes UPN177

description: Hybridized to 250K_Nsp


title: Ascl1-48h_rep2

source_name: Ascl1, -Dox, 48h

value: Ascl1 clone12, Dox-, 48h #2


title: Ascl2-48h_rep1

source_name: Ascl2, -Dox, 48h

value: Ascl2 clone21, Dox-, 48h #1


title: Ascl1+48h_rep1

source_name: Ascl1, +Dox, 48h

value: Ascl1 clone12, Dox+, 48h #1


title: Granulocytes UPN176

description: Hybridized to 250K_Nsp

source_name: peripheral blood


title: Ascl2+48h_rep2

source_name: Ascl2, +Dox, 48h

value: Ascl2 clone21, Dox+, 48h #2


title: Ascl1-48h_rep1

value: Ascl1 clone12, Dox-, 48h #1

source_name: Universal Mouse Reference 129ES Cell


title: Ascl2-48h_rep2

value: Ascl2 clone21, Dox-, 48h #2


title: Granulocytes UPN175

description: Hybridized to 250K_Nsp


title: Granulocytes UPN170

description: Hybridized to 250K_Nsp


title: Gata3-48h_rep1

source_name: Gata3, -Dox, 48h

value: Embryonic Stem Cells

value: Gata3 clone14, Dox-, 48h #1


title: Gata3-48h_rep2

value: male

value: Gata3 clone14, Dox-, 48h #2


title: Ascl2+48h_rep1

value: embryo

value: Ascl2 clone21, Dox+, 48h #1


title: Klf4-48h_rep2

source_name: Klf4, -Dox, 48h

value: Klf4 clone16, Dox-, 48h #2

value: mixed


title: Sox2+48h_rep2

source_name: Sox2, +Dox, 48h

value: Sox2 clone3, Dox+, 48h #2


title: Klf4-48h_rep1

value: Klf4 clone16, Dox-, 48h #1


title: Granulocytes UPN172

description: Hybridized to 250K_Nsp

value: granulocytes

value: essential thrombocythemia


title: Sox2-48h_rep2

source_name: Sox2, -Dox, 48h

value: Sox2 clone3, Dox-, 48h #2


title: Granulocytes UPN162

description: Hybridized to 250K_Nsp

value: primary myelofibrosis


title: Sox2+48h_rep1

value: Sox2 clone3, Dox+, 48h #1


title: Gata3+48h_rep2

source_name: Gata3, +Dox, 48h

value: Gata3 clone14, Dox+, 48h #3


title: Pou5f1-48h_rep1

source_name: Pou5f1, -Dox, 48h

value: Pou5f1 clone18, Dox-, 48h #1


title: Pou5f1-48h_rep2

value: Embryonic Stem Cells

value: Pou5f1 clone18, Dox-, 48h #2


title: Granulocytes UPN169

description: Hybridized to 250K_Nsp


title: Pou5f1+48h_rep2

source_name: Pou5f1, +Dox, 48h

value: male

value: Pou5f1 clone18, Dox+, 48h #2


title: Gata3+48h_rep1

value: embryo

value: Gata3 clone14, Dox+, 48h #2


title: T-48h_rep2

source_name: T, -Dox, 48h

value: Brachyury (T) clone21, Dox-, 48h #2


title: Ascl1+48h_rep2

value: Ascl1 clone12, Dox+, 48h #2

value: mixed


title: T+48h_rep1

source_name: T, +Dox, 48h

value: Brachyury (T) clone21, Dox+, 48h #1


title: Granulocytes UPN135

description: Hybridized to 250K_Nsp

value: granulocytes


title: Granulocytes UPN161

description: Hybridized to 250K_Nsp


title: Granulocytes UPN171

description: Hybridized to 250K_Nsp

value: essential thrombocythemia


title: Granulocytes UPN134

description: Hybridized to 250K_Nsp


title: Sox2-24h_rep2

source_name: Sox2, -Dox, 24h

value: Sox2 clone3, Dox-, 24h #2


title: Sox2-24h_rep1

value: Sox2 clone3, Dox-, 24h #1


title: Granulocytes UPN132

description: Hybridized to 250K_Nsp

value: primary myelofibrosis


title: Pou5f1-24h_rep2

source_name: Pou5f1, -Dox, 24h

value: Pou5f1 clone18, Dox-, 24h #2


title: T+48h_rep2

value: Brachyury (T) clone21, Dox+, 48h #2


title: Granulocytes UPN129

description: Hybridized to 250K_Nsp


title: Pou5f1-24h_rep1

value: Embryonic Stem Cells

value: Pou5f1 clone18, Dox-, 24h #1


title: Granulocytes UPN136

description: Hybridized to 250K_Nsp


title: Esx1-48h_rep2

source_name: Esx1, -Dox, 48h

value: male

value: Esx1 clone16, Dox-, 48h #3


title: Sox2-48h_rep1

value: embryo

value: Sox2 clone3, Dox-, 48h #1


title: Pou5f1+48h_rep1

value: Pou5f1 clone18, Dox+, 48h #1


title: T-24h_rep1

source_name: T, -Dox, 24h

value: Brachyury (T) clone21, Dox-, 24h #1


title: T-24h_rep2

value: Brachyury (T) clone21, Dox-, 24h #2

value: mixed


title: Granulocytes UPN127

description: Hybridized to 250K_Nsp

value: granulocytes


title: Granulocytes UPN125

description: Hybridized to 250K_Nsp


title: Esx1-48h_rep1

value: Esx1 clone16, Dox-, 48h #2


title: Granulocytes UPN130

description: Hybridized to 250K_Nsp


title: Granulocytes UPN128

description: Hybridized to 250K_Nsp


title: Esx1+48h_rep2

source_name: Esx1, +Dox, 48h

value: Esx1 clone16, Dox+, 48h #3


title: Granulocytes UPN122

description: Hybridized to 250K_Nsp

source_name: peripheral blood

value: post-polycythemia vera myelofibrosis


title: Granulocytes UPN123

description: Hybridized to 250K_Nsp

value: primary myelofibrosis


title: Granulocytes UPN133

description: Hybridized to 250K_Nsp


title: Myc-48h_rep1

source_name: Myc, -Dox, 48h

value: Myc clone16, Dox-, 48h #2


title: Myc+48h_rep1

source_name: Myc, +Dox, 48h

value: Myc clone16, Dox+, 48h #1

source_name: Universal Mouse Reference 129ES Cell


title: Granulocytes UPN131

description: Hybridized to 250K_Nsp


title: T-48h_rep1

value: Embryonic Stem Cells

value: Brachyury (T) clone21, Dox-, 48h #1


title: T+24h_rep2

source_name: T, +Dox, 24h

value: male

value: Brachyury (T) clone21, Dox+, 24h #2


title: Myc-48h_rep2

value: embryo

value: Myc clone16, Dox-, 48h #3


title: T+24h_rep1

value: Brachyury (T) clone21, Dox+, 24h #1


title: Myc+48h_rep2

value: Myc clone16, Dox+, 48h #2


title: Cdx2+48h_rep1

source_name: Cdx2, +Dox, 48h

value: Cdx2 clone6, Dox+, 48h #1


title: T+0h_rep2

source_name: T, +Dox, 0h

treatment_protocol: Day 0: Cells were plated in regular ES medium with Doxycycline (0.2ug/ml) and Puromycin (1.5ug/ml) medium. After 24 hours, the cells were harvested in Trizol. There was no medium change on the day of RNA harvest.

value: Brachyury (T) clone21, Dox+, 0h #2

value: mixed


title: Granulocytes UPN121

description: Hybridized to 250K_Nsp

value: granulocytes


title: T+0h_rep1

value: Brachyury (T) clone21, Dox+, 0h #1


title: Granulocytes UPN119

description: Hybridized to 250K_Nsp


title: Granulocytes UPN120

description: Hybridized to 250K_Nsp


title: Granulocytes UPN118

description: Hybridized to 250K_Nsp

value: post-polycythemia vera myelofibrosis


title: Esx1+48h_rep1

value: Esx1 clone16, Dox+, 48h #2


title: Pou5f1+24h_rep2

source_name: Pou5f1, +Dox, 24h

value: Pou5f1 clone18, Dox+, 24h #3


title: Pou5f1+24h_rep1

value: Pou5f1 clone18, Dox+, 24h #1


title: Sox2+24h_rep2

source_name: Sox2, +Dox, 24h

value: Embryonic Stem Cells

value: Sox2 clone3, Dox+, 24h #2


title: Sox2+0h_rep2

source_name: Sox2, +Dox, 0h

value: male

value: Sox2 clone3, Dox+, 0h #2


title: Sox2+24h_rep1

value: embryo

value: Sox2 clone3, Dox+, 24h #1


title: Sox2+0h_rep1

value: Sox2 clone3, Dox+, 0h #1


title: Granulocytes UPN117

description: Hybridized to 250K_Nsp

value: primary myelofibrosis


title: Pou5f1+0h_rep2

source_name: Pou5f1, +Dox, 0h

value: Pou5f1 clone18, Dox+, 0h #2


title: Pou5f1+0h_rep1

value: Pou5f1 clone18, Dox+, 0h #1


title: ES[MC1R(20):tetRhox6(24)]_day2_Dox- rep2

description: Rhox6 clone24, Dox-, 48h #2

data_processing: Data are extracted with Agilent Feature Extraction Software. The data were further processed with NIA ANOVA tool utilities. It is calculated with the following method: (1) Take values from the columns gDyeNormSignal, rDyeNormSignal in the raw files and log-transform them using: log10(max(x,1)). These values will be referenced below as Xgi and Xri where i is array number. (2) Take average of Xri's for the oligo among all arrays in the series: AverXr = average(Xri). (3) For each array estimate Yi = Xgi-Xri+AverXr (4) Round Yi to 4 decimal digits. This is used as the normalized VALUE. More detailed information with error correction can be found at http://lgsun.grc.nia.nih.gov/ANOVA/help.html#arrayjoin

extract_protocol: The samples were dissolved in the well with TRIzol reagent 1/2 mL.  They were then transferred to Phase Lock Gel Heavy tubes (eppendorf) and 0.2 volumes of chloroform (Sigma-Aldrich) was added to each sample.  They were mixed by hand and allowed to stand for 2-5 min at room temperature. The samples were then separated by centrifugation for 5 minutes at 15,300 rpm on an eppendorf centrifuge at 4C. The aqeous phase was transferred to another eppendorf tube, and 0.8 volumes of ice-cold isopropanol was added. They were allowed to incubate  for a minimum of 10 minutes at room temperature. If longer, they were placed at 4C. The sample was centrifuged again at the same conditions for 15 minutes. After centrifugation, the liquid was dumped out of the tubes and the pellet was washed with 1 mL of ice-cold 70% ethanol. The tube was spun  for 5 minutes, then the ethanol was dumped out.  Excess was removed with a pipette and the pellet was allowed to air dry until no liquid remained, but no longer.  ddH2O was then added in the appropriate volume, the sample was allowed to dissolve for 5 minutes at 55C and then transferred to -80C for storage.

value: day 2 embryo

tag: culture condition

value: Dox-

tag: individual identifier

extract_protocol: Total RNA was extracted from cultured cells using a Stratagene Absolutely RNA kit. DNase-treated total RNA samples from 11 cultured cell lines derived from embryo, embryo fibroblast, kidney, liver/hepatocyte, lung/alveolar macrophage, B-lymphocyte, T-lymphocyte (thymus), mammary gland, muscle myoblast, skin, and testis were pooled in equal parts. The resulting URM RNA was mixed with 129ES cell RNA (Lif+) at 2:1 ratio and 2.5ug of mixed RNA was used for labeling in each tube

value: mixed


title: ES[MC1R(20):tetTuba1a(12)]_day2_Dox- rep2

description: Tuba1a clone12, Dox-, 48h #2


title: ES[MC1R(20):tetSuz12(9)]_day2_Dox- rep1

description: Suz12 clone9, Dox-, 48h #1


title: Granulocytes UPN108

description: Hybridized to 250K_Nsp

value: granulocytes


title: Granulocytes UPN110

description: Hybridized to 250K_Nsp


title: ES[MC1R(20):tetTcf3(7)]_day2_Dox- rep2

description: Tcf3 clone7, Dox-, 48h #3


title: Granulocytes UPN116

description: Hybridized to 250K_Nsp


title: Granulocytes UPN109

description: Hybridized to 250K_Nsp


title: ES[MC1R(20):tetTcf3(7)]_day2_Dox- rep1

description: Tcf3 clone7, Dox-, 48h #1


title: ES[MC1R(20):tetTcf3(7)]_day2_Dox+ rep2

description: Tcf3 clone7, Dox+, 48h #2

value: Dox+


title: Granulocytes UPN106

description: Hybridized to 250K_Nsp


title: Granulocytes UPN102

description: Hybridized to 250K_Nsp

value: post-polycythemia vera myelofibrosis


title: ES[MC1R(20):tetMycn(44)]_day2_Dox- rep2

description: Mycn clone44, Dox-, 48h #3


title: ES[MC1R(20):tetElf1(21)]_day2_Dox- rep2

description: Elf1 clone21, Dox-, 48h #2


title: Granulocytes UPN105

description: Hybridized to 250K_Nsp


title: Granulocytes UPN104

description: Hybridized to 250K_Nsp


title: ES[MC1R(20):tetElf1(21)]_day2_Dox- rep1

description: Elf1 clone21, Dox-, 48h #1


title: Granulocytes UPN107

description: Hybridized to 250K_Nsp


title: ES[MC1R(20):tetId1(1)]_day2_Dox- rep1

description: Id1 clone1, Dox-, 48h #1


title: ES[MC1R(20):tetId1(1)]_day2_Dox+ rep2

description: Id1 clone1, Dox+, 48h #2


title: ES[MC1R(20):tetElf1(21)]_day2_Dox+ rep2

description: Elf1 clone21, Dox+, 48h #2


title: Granulocytes UPN103

description: Hybridized to 250K_Nsp


title: Granulocytes UPN67

description: Hybridized to 250K_Nsp

value: polycythemia vera


title: ES[MC1R(20):tetId1(1)]_day2_Dox- rep2

description: Id1 clone1, Dox-, 48h #2

value: Embryonic Stem Cells


title: ES[MC1R(20):tetSfpi1(10)]_day2_Dox- rep2

description: Sfpi1 clone10, Dox-, 48h #2


title: Granulocytes UPN68

description: Hybridized to 250K_Nsp


title: ES[MC1R(20):tetSfpi1(10)]_day2_Dox+ rep2

description: Sfpi1 clone10, Dox+, 48h #2


title: Granulocytes UPN66

description: Hybridized to 250K_Nsp


title: Granulocytes UPN69

description: Hybridized to 250K_Nsp


title: ES[MC1R(20):tetSfpi1(10)]_day2_Dox- rep1

description: Sfpi1 clone10, Dox-, 48h #1


title: Granulocytes UPN65

description: Hybridized to 250K_Nsp


title: ES[MC1R(20):tetKlf4(16)]_day2_Dox+ rep2

description: Klf4 clone16, Dox+, 48h #2


title: Granulocytes UPN64

description: Hybridized to 250K_Nsp


title: ES[MC1R(20):tetKlf4(16)]_day2_Dox+ rep1

description: Klf4 clone16, Dox+, 48h #1


title: Granulocytes UPN60

description: Hybridized to 250K_Nsp


title: Granulocytes UPN62

description: Hybridized to 250K_Nsp


title: ES[MC1R(20):tetNr5a2(7)]_day2_Dox- rep2

description: Nr5a2 clone7, Dox-, 48h #2


title: ES[MC1R(20):tetNr5a2(7)]_day2_Dox- rep1

description: Nr5a2 clone7, Dox-, 48h #1


title: Granulocytes UPN101

description: Hybridized to 250K_Nsp


title: Granulocytes UPN61

description: Hybridized to 250K_Nsp


title: Granulocytes UPN63

description: Hybridized to 250K_Nsp


title: Granulocytes UPN59

description: Hybridized to 250K_Nsp


title: Granulocytes UPN58

description: Hybridized to 250K_Nsp


title: Granulocytes UPN57

description: Hybridized to 250K_Nsp


title: Granulocytes UPN54

description: Hybridized to 250K_Nsp


title: Granulocytes UPN55

description: Hybridized to 250K_Nsp


title: ES[MC1R(20):tetMybl2(6)]_day2_Dox+ rep2

description: Mybl2 clone6, Dox+, 48h #2


title: ES[MC1R(20):tetMybl2(6)]_day2_Dox- rep2

description: Mybl2 clone6, Dox-, 48h #2


title: ES[MC1R(20):tetMsc(24)]_day2_Dox- rep2

description: Msc clone24, Dox-, 48h #2


title: ES[MC1R(20):tetSall4(17)]_day2_Dox- rep2

description: Sall4 clone17, Dox-, 48h #2


title: ES[MC1R(20):tetMsc(24)]_day2_Dox- rep1

description: Msc clone24, Dox-, 48h #1


title: Granulocytes UPN56

description: Hybridized to 250K_Nsp


title: ES[MC1R(20):tetSall4(17)]_day2_Dox- rep1

description: Sall4 clone17, Dox-, 48h #1


title: ES[MC1R(20):tetMybl2(6)]_day2_Dox- rep1

description: Mybl2 clone6, Dox-, 48h #1


title: ES[MC1R(20):tetSall4(17)]_day2_Dox+ rep2

description: Sall4 clone17, Dox+, 48h #2


title: Granulocytes UPN51

description: Hybridized to 250K_Nsp


title: ES[MC1R(20):tetSall4(17)]_day2_Dox+ rep1

description: Sall4 clone17, Dox+, 48h #1


title: ES[MC1R(20):tetNr0b1(15)]_day2_Dox- rep2

description: Nr0b1  clone15, Dox-, 48h #2


title: Granulocytes UPN46

description: Hybridized to 250K_Nsp


title: Granulocytes UPN48

description: Hybridized to 250K_Nsp


title: ES[MC1R(20):tetNr0b1(15)]_day2_Dox+ rep2

description: Nr0b1  clone15, Dox+, 48h #3


title: ES[MC1R(20):tetNr0b1(15)]_day2_Dox- rep1

description: Nr0b1  clone15, Dox-, 48h #1


title: Granulocytes UPN53

description: Hybridized to 250K_Nsp


title: ES[MC1R(20):tetControl(13)]_day2_Dox+ rep2

description: Control clone13, Dox+, 48h #2

value: Control+48h_rep2; ES[MC1R(20):tetControl(13)]_day2_Dox+_repB; Control clone13, Dox+, 48h #2; 251508710637A4


title: Granulocytes UPN45

description: Hybridized to 250K_Nsp


title: Granulocytes UPN50

description: Hybridized to 250K_Nsp


title: ES[MC1R(20):tetControl(13)]_day2_Dox- rep2

description: Control clone13, Dox-, 48h #2

value: male

value: Control-48h_rep2; ES[MC1R(20):tetControl(13)]_day2_Dox-_repB; Control clone13, Dox-, 48h #2; 251508710638A1


title: Granulocytes UPN49

description: Hybridized to 250K_Nsp


title: ES[MC1R(20):tetTuba1a(12)]_day2_Dox+ rep2

description: Tuba1a clone12, Dox+, 48h #2


title: ES[MC1R(20):tetTuba1a(12)]_day2_Dox- rep1

description: Tuba1a clone12, Dox-, 48h #1


title: Granulocytes UPN52

description: Hybridized to 250K_Nsp


title: Granulocytes UPN44

description: Hybridized to 250K_Nsp


title: ES[MC1R(20):tetCdx2(6)]_day2_Dox- rep2

description: Cdx2 clone6, Dox-, 48h #4


title: ES[MC1R(20):tetCdx2(6)]_day2_Dox- rep1

description: Cdx2 clone6, Dox-, 48h #3


title: ES[MC1R(20):tetControl(13)]_day2_Dox+ rep1

description: Control clone13, Dox+, 48h #1

value: Control+48h_rep1; ES[MC1R(20):tetControl(13)]_day2_Dox+_repA; Control clone13, Dox+, 48h #1; 251508710637A3


title: Granulocytes UPN37

description: Hybridized to 250K_Nsp


title: Granulocytes UPN41

description: Hybridized to 250K_Nsp


title: ES[MC1R(20):tetCdx2(6)]_day2_Dox+ rep2

description: Cdx2 clone6, Dox+, 48h #3


title: ES[MC1R(20):tetTcf3(7)]_day2_Dox+ rep1

description: Tcf3 clone7, Dox+, 48h #1


title: Granulocytes UPN43

description: Hybridized to 250K_Nsp


title: ES[MC1R(20):tetElf1(21)]_day2_Dox+ rep1

description: Elf1 clone21, Dox+, 48h #1


title: ES[MC1R(20):tetId1(1)]_day2_Dox+ rep1

description: Id1 clone1, Dox+, 48h #1


title: Granulocytes UPN40

description: Hybridized to 250K_Nsp


title: Granulocytes UPN36

description: Hybridized to 250K_Nsp


title: ES[MC1R(20):tetWhsc2(18)]_day2_Dox+ rep1

description: Whsc2 clone18, Dox+, 48h #1


title: ES[MC1R(20):tetSfpi1(10)]_day2_Dox+ rep1

description: Sfpi1 clone10, Dox+, 48h #1


title: Granulocytes UPN33

description: Hybridized to 250K_Nsp


title: Granulocytes UPN38

description: Hybridized to 250K_Nsp


title: ES[MC1R(20):tetNanog(24)]_day2_Dox- rep2

description: Nanog clone24, Dox-, 48h #3

value: Nanog-48h_rep2; ES[MC1R(20):tetNanog(24)]_day2_Dox-_repC; Nanog clone24, Dox-, 48h #3; 251508710602A4


title: Granulocytes UPN42

description: Hybridized to 250K_Nsp


title: ES[MC1R(20):tetNanog(24)]_day2_Dox- rep1

description: Nanog clone24, Dox-, 48h #2

value: Nanog-48h_rep1; ES[MC1R(20):tetNanog(24)]_day2_Dox-_repB; Nanog clone24, Dox-, 48h #2; 251508710602A3


title: Granulocytes UPN31

description: Hybridized to 250K_Nsp


title: ES[MC1R(20):tetNanog(24)]_day2_Dox+ rep2

description: Nanog clone24, Dox+, 48h #2

value: Nanog+48h_rep2; ES[MC1R(20):tetNanog(24)]_day2_Dox+_repB; Nanog clone24, Dox+, 48h #2; 251508710602A2


title: Granulocytes UPN34

description: Hybridized to 250K_Nsp


title: Granulocytes UPN35

description: Hybridized to 250K_Nsp


title: Granulocytes UPN28

description: Hybridized to 250K_Nsp


title: ES[MC1R(20):tetNanog(24)]_day2_Dox+ rep1

description: Nanog clone24, Dox+, 48h #1

value: Nanog+48h_rep1; ES[MC1R(20):tetNanog(24)]_day2_Dox+_repA; Nanog clone24, Dox+, 48h #1; 251508710602A1


title: Granulocytes UPN29

description: Hybridized to 250K_Nsp


title: Granulocytes UPN27

description: Hybridized to 250K_Nsp


title: Granulocytes UPN30

description: Hybridized to 250K_Nsp


title: Granulocytes UPN24

description: Hybridized to 250K_Nsp


title: ES[MC1R(20):tetDnmt3b(22)]_day2_Dox- rep1

description: Dnmt3b clone22, Dox-, 48h #2


title: Granulocytes UPN20

description: Hybridized to 250K_Nsp

value: primary myelofibrosis


title: Granulocytes UPN26

description: Hybridized to 250K_Nsp


title: Granulocytes UPN22

description: Hybridized to 250K_Nsp


title: ES[MC1R(20):tetDnmt3b(22)]_day2_Dox+ rep2

description: Dnmt3b clone22, Dox+, 48h #2

value: day 2 embryo


title: Granulocytes UPN18

description: Hybridized to 250K_Nsp


title: ES[MC1R(20):tetDnmt3b(22)]_day2_Dox+ rep1

description: Dnmt3b clone22, Dox+, 48h #1


title: ES[MC1R(20):tetRhox6(24)]_day2_Dox- rep1

description: Rhox6 clone24, Dox-, 48h #1

value: Dox-


title: ES[MC1R(20):tetRhox6(24)]_day2_Dox+ rep2

description: Rhox6 clone24, Dox+, 48h #2

value: mixed


title: Granulocytes UPN21

description: Hybridized to 250K_Nsp

value: granulocytes


title: ES[MC1R(20):tetRxra(2)]_day2_Dox+ rep2

description: Rxra clone2, Dox+, 48h #2

value: Dox+


title: ES[MC1R(20):tetRhox6(24)]_day2_Dox+ rep1

description: Rhox6 clone24, Dox+, 48h #1


title: ES[MC1R(20):tetRxra(2)]_day2_Dox- rep1

description: Rxra clone2, Dox-, 48h #1


title: ES[MC1R(20):tetRxra(2)]_day2_Dox- rep2

description: Rxra clone2, Dox-, 48h #3


title: ES[MC1R(20):tetAscl1(12)]_day2_Dox+ rep2

description: Ascl1 clone12, Dox+, 48h #2


title: ES[MC1R(20):tetRxra(2)]_day2_Dox+ rep1

description: Rxra clone2, Dox+, 48h #1


title: ES[MC1R(20):tetAscl1(12)]_day2_Dox- rep2

description: Ascl1 clone12, Dox-, 48h #2


title: ES[MC1R(20):tetAscl1(12)]_day2_Dox+ rep1

description: Ascl1 clone12, Dox+, 48h #1


title: ES[MC1R(20):tetZscan4c(5)]_day2_Dox- rep2

description: Zscan4c clone5, Dox-, 48h #3

value: Zscan4c-48h_rep2; ES[MC1R(20):tetZscan4c(5)]_day2_Dox-_repC; Zscan4c clone5, Dox-, 48h #3; 251508710595A4


title: Granulocytes UPN14

description: Hybridized to 250K_Nsp


title: Granulocytes UPN12

description: Hybridized to 250K_Nsp


title: ES[MC1R(20):tetAscl1(12)]_day2_Dox- rep1

description: Ascl1 clone12, Dox-, 48h #1


title: Granulocytes UPN19

description: Hybridized to 250K_Nsp


title: ES[MC1R(20):tetZscan4c(5)]_day2_Dox+ rep2

description: Zscan4c clone5, Dox+, 48h #3

value: Zscan4c+48h_rep2; ES[MC1R(20):tetZscan4c(5)]_day2_Dox+_repC; Zscan4c clone5, Dox+, 48h #3; 251508710595A2


title: ES[MC1R(20):tetZscan4c(5)]_day2_Dox- rep1

description: Zscan4c clone5, Dox-, 48h #2

value: Embryonic Stem Cells

value: Zscan4c-48h_rep1; ES[MC1R(20):tetZscan4c(5)]_day2_Dox-_repB; Zscan4c clone5, Dox-, 48h #2; 251508710595A3


title: ES[MC1R(20):tetDnmt3b(22)]_day2_Dox- rep2

description: Dnmt3b clone22, Dox-, 48h #3

value: male


title: ES[MC1R(20):tetSmad7(3)]_day2_Dox- rep1

description: Smad7 clone3, Dox-, 48h #2


title: ES[MC1R(20):tetSmad7(3)]_day2_Dox+ rep2

description: Smad7 clone3, Dox+, 48h #2


title: ES[MC1R(20):tetZscan4c(5)]_day2_Dox+ rep1

description: Zscan4c clone5, Dox+, 48h #1

value: Zscan4c+48h_rep1; ES[MC1R(20):tetZscan4c(5)]_day2_Dox+_repA; Zscan4c clone5, Dox+, 48h #1; 251508710595A1


title: ES[MC1R(20):tetEtv3(15)]_day2_Dox- rep2

description: Etv3 clone15, Dox-, 48h #2


title: Granulocytes UPN16

description: Hybridized to 250K_Nsp


title: ES[MC1R(20):tetEtv3(15)]_day2_Dox- rep1

description: Etv3 clone15, Dox-, 48h #1


title: ES[MC1R(20):tetSmad7(3)]_day2_Dox+ rep1

description: Smad7 clone3, Dox+, 48h #1


title: ES[MC1R(20):tetEtv3(15)]_day2_Dox+ rep2

description: Etv3 clone15, Dox+, 48h #2


title: Granulocytes UPN15

description: Hybridized to 250K_Nsp


title: ES[MC1R(20):tetAscl2(21)]_day2_Dox- rep2

description: Ascl2 clone21, Dox-, 48h #2


title: ES[MC1R(20):tetEtv3(15)]_day2_Dox+ rep1

description: Etv3 clone15, Dox+, 48h #1


title: ES[MC1R(20):tetAscl2(21)]_day2_Dox+ rep2

description: Ascl2 clone21, Dox+, 48h #2


title: ES[MC1R(20):tetAscl2(21)]_day2_Dox- rep1

description: Ascl2 clone21, Dox-, 48h #1


title: Granulocytes UPN6

description: Hybridized to 250K_Nsp


title: Granulocytes UPN7

description: Hybridized to 250K_Nsp


title: Granulocytes UPN9

description: Hybridized to 250K_Nsp


title: ES[MC1R(20):tetSmad4(14)]_day2_Dox+ rep2

description: Smad4 clone14, Dox+, 48h #2


title: ES[MC1R(20):tetSmad4(14)]_day2_Dox- rep1

description: Smad4 clone14, Dox-, 48h #1


title: Granulocytes UPN10

description: Hybridized to 250K_Nsp


title: Granulocytes UPN13

description: Hybridized to 250K_Nsp


title: ES[MC1R(20):tetSmad4(14)]_day2_Dox+ rep1

description: Smad4 clone14, Dox+, 48h #1


title: ES[MC1R(20):tetSmad4(14)]_day2_Dox- rep2

description: Smad4 clone14, Dox-, 48h #2


title: ES[MC1R(20):tetAscl2(21)]_day2_Dox+ rep1

description: Ascl2 clone21, Dox+, 48h #1


title: ES[MC1R(20):tetFoxj2(6)]_day2_Dox- rep1

description: Foxj2 clone6, Dox-, 48h #1


title: ES[MC1R(20):tetFoxj2(6)]_day2_Dox+ rep2

description: Foxj2 clone6, Dox+, 48h #2


title: ES[MC1R(20):tetFoxj2(6)]_day2_Dox+ rep1

description: Foxj2 clone6, Dox+, 48h #1


title: ES[MC1R(20):tetDlx3(3)]_day2_Dox- rep2

description: Dlx3 clone3, Dox-, 48h #3


title: ES[MC1R(20):tetDlx3(3)]_day2_Dox- rep1

description: Dlx3 clone3, Dox-, 48h #1


title: Granulocytes UPN3

description: Hybridized to 250K_Nsp


title: Granulocytes UPN4

description: Hybridized to 250K_Nsp


title: ES[MC1R(20):tetDlx3(3)]_day2_Dox+ rep2

description: Dlx3 clone3, Dox+, 48h #3


title: Granulocytes UPN5

description: Hybridized to 250K_Nsp


title: ES[MC1R(20):tetNr2f2(5)]_day2_Dox- rep1

description: Nr2f2 clone5, Dox-, 48h #1


title: ES[MC1R(20):tetFoxj2(6)]_day2_Dox- rep2

description: Foxj2 clone6, Dox-, 48h #2


title: ES[MC1R(20):tetNr2f2(5)]_day2_Dox+ rep2

description: Nr2f2 clone5, Dox+, 48h #3


title: Granulocytes UPN2

description: Hybridized to 250K_Nsp


title: Granulocytes UPN1

description: Hybridized to 250K_Nsp


title: ES[MC1R(20):tetNr2f2(5)]_day2_Dox+ rep1

description: Nr2f2 clone5, Dox+, 48h #1


title: ES[MC1R(20):tetDlx3(3)]_day2_Dox+ rep1

description: Dlx3 clone3, Dox+, 48h #1


title: ES[MC1R(20):tetGata3(14)]_day2_Dox+ rep2

description: Gata3 clone14, Dox+, 48h #3


title: ES[MC1R(20):tetGata3(14)]_day2_Dox- rep2

description: Gata3 clone14, Dox-, 48h #2


title: ES[MC1R(20):tetNrip1(20)]_day2_Dox+ rep2

description: Nrip1 clone20, Dox+, 48h #2


title: ES[MC1R(20):tetNrip1(20)]_day2_Dox- rep1

description: Nrip1 clone20, Dox-, 48h #2


title: ES[MC1R(20):tetNrip1(20)]_day2_Dox+ rep1

description: Nrip1 clone20, Dox+, 48h #1


title: ES[MC1R(20):tetNrip1(20)]_day2_Dox- rep2

description: Nrip1 clone20, Dox-, 48h #3


title: ES[MC1R(20):tetGata3(14)]_day2_Dox+ rep1

description: Gata3 clone14, Dox+, 48h #2


title: ES[MC1R(20):tetZfand3(6)]_day2_Dox+ rep1

description: Zfand3 clone6, Dox+, 48h #1


title: ES[MC1R(20):tetZfand3(6)]_day2_Dox- rep1

description: Zfand3 clone6, Dox-, 48h #2


title: ES[MC1R(20):tetFem1b(6)]_day2_Dox- rep1

description: Fem1b clone6, Dox-, 48h #2


title: ES[MC1R(20):tetFem1b(6)]_day2_Dox+ rep1

description: Fem1b clone6, Dox+, 48h #1


title: ES[MC1R(20):tetZfand3(6)]_day2_Dox- rep2

description: Zfand3 clone6, Dox-, 48h #3


title: ES[MC1R(20):tetFem1b(6)]_day2_Dox+ rep2

description: Fem1b clone6, Dox+, 48h #3


title: ES[MC1R(20):tetGata3(14)]_day2_Dox- rep1

description: Gata3 clone14, Dox-, 48h #1


title: ES[MC1R(20):tetZfand3(6)]_day2_Dox+ rep2

description: Zfand3 clone6, Dox+, 48h #2


title: Granulocytes UPN8

description: Hybridized to 250K_Nsp


title: ES[MC1R(20):tetTcf4(9)]_day2_Dox- rep2

description: Tcf4 clone9, Dox-, 48h #3


title: ES[MC1R(20):tetSmad7(3)]_day2_Dox- rep2

description: Smad7 clone3, Dox-, 48h #3


title: ES[MC1R(20):tetTcf4(9)]_day2_Dox- rep1

description: Tcf4 clone9, Dox-, 48h #2


title: Granulocytes UPN11

description: Hybridized to 250K_Nsp


title: ES[MC1R(20):tetMyoD1(14)]_day2_Dox- rep2

description: MyoD1 clone14, Dox-, 48h #3


title: ES[MC1R(20):tetTcf4(9)]_day2_Dox+ rep2

description: Tcf4 clone9, Dox+, 48h #3


title: ES[MC1R(20):tetTcf4(9)]_day2_Dox+ rep1

description: Tcf4 clone9, Dox+, 48h #2


title: ES[MC1R(20):tetFem1b(6)]_day2_Dox- rep2

description: Fem1b clone6, Dox-, 48h #3


title: ES[MC1R(20):tetMyoD1(14)]_day2_Dox+ rep2

description: MyoD1 clone14, Dox+, 48h #2


title: ES[MC1R(20):tetGadd45a(6)]_day2_Dox- rep1

description: Gadd45a clone6, Dox-, 48h #2


title: ES[MC1R(20):tetSox9(13)]_day2_Dox+ rep2

description: Sox9 clone13, Dox+, 48h #2


title: ES[MC1R(20):tetMyoD1(14)]_day2_Dox- rep1

description: MyoD1 clone14, Dox-, 48h #2


title: ES[MC1R(20):tetSox9(13)]_day2_Dox- rep2

description: Sox9 clone13, Dox-, 48h #2


title: ES[MC1R(20):tetMef2c(5)]_day2_Dox- rep1

description: Mef2c clone5, Dox-, 48h #1


title: ES[MC1R(20):tetSox9(13)]_day2_Dox- rep1

description: Sox9 clone13, Dox-, 48h #3


title: ES[MC1R(20):tetMyoD1(14)]_day2_Dox+ rep1

description: MyoD1 clone14, Dox+, 48h #1


title: ES[MC1R(20):tetMef2c(5)]_day2_Dox- rep2

description: Mef2c clone5, Dox-, 48h #2


title: ES[MC1R(20):tetGadd45a(6)]_day2_Dox- rep2

description: Gadd45a clone6, Dox-, 48h #3


title: ES[MC1R(20):tetSox9(13)]_day2_Dox+ rep1

description: Sox9 clone13, Dox+, 48h #1


title: ES[MC1R(20):tetMef2c(5)]_day2_Dox+ rep2

description: Mef2c clone5, Dox+, 48h #2


title: ES[MC1R(20):tetSmad1(5)]_day2_Dox- rep1

description: Smad1 clone5, Dox-, 48h #1


title: ES[MC1R(20):tetGadd45a(6)]_day2_Dox+ rep2

description: Gadd45a clone6, Dox+, 48h #3


title: ES[MC1R(20):tetSmad1(5)]_day2_Dox+ rep2

description: Smad1 clone5, Dox+, 48h #2


title: ES[MC1R(20):tetSmad1(5)]_day2_Dox+ rep1

description: Smad1 clone5, Dox+, 48h #1


title: ES[MC1R(20):tetGadd45a(6)]_day2_Dox+ rep1

description: Gadd45a clone6, Dox+, 48h #1


title: ES[MC1R(20):tetEomes(35)]_day2_Dox+ rep1

description: Eomes clone35, Dox+, 48h #1

value: Eomes+48h_rep1; ES[MC1R(20):tetEomes(35)]_day2_Dox+_repA; Eomes clone35, Dox+, 48h #1; 251508710575A1


title: ES[MC1R(20):tetMef2c(5)]_day2_Dox+ rep1

description: Mef2c clone5, Dox+, 48h #1


title: ES[MC1R(20):tetSmad1(5)]_day2_Dox- rep2

description: Smad1 clone5, Dox-, 48h #3


title: ES[MC1R(20):tetOtx2(15)]_day2_Dox+ rep2

description: Otx2 clone15, Dox+, 48h #2


title: ES[MC1R(20):tetEomes(35)]_day2_Dox- rep1

description: Eomes clone35, Dox-, 48h #1

value: Eomes-48h_rep1; ES[MC1R(20):tetEomes(35)]_day2_Dox-_repA; Eomes clone35, Dox-, 48h #1; 251508710575A3


title: ES[MC1R(20):tetOtx2(15)]_day2_Dox- rep1

description: Otx2 clone15, Dox-, 48h #1


title: ES[MC1R(20):tetEomes(35)]_day2_Dox+ rep2

description: Eomes clone35, Dox+, 48h #3

value: Eomes+48h_rep2; ES[MC1R(20):tetEomes(35)]_day2_Dox+_repC; Eomes clone35, Dox+, 48h #3; 251508710575A2


title: ES[MC1R(20):tetOtx2(15)]_day2_Dox+ rep1

description: Otx2 clone15, Dox+, 48h #1


title: Mononuclear cells Sty28

description: Hybridized to 250K_Sty

value: mononuclear cells

value: remission


title: ES[MC1R(20):tetKlf4(16)]_day2_Dox- rep1

description: Klf4 clone16, Dox-, 48h #1


title: ES[MC1R(20):tetWhsc2(18)]_day2_Dox- rep2

description: Whsc2 clone18, Dox-, 48h #2


title: ES[MC1R(20):tetEomes(35)]_day2_Dox- rep2

description: Eomes clone35, Dox-, 48h #2

value: Eomes-48h_rep2; ES[MC1R(20):tetEomes(35)]_day2_Dox-_repB; Eomes clone35, Dox-, 48h #2; 251508710575A4


title: ES[MC1R(20):tetOtx2(15)]_day2_Dox- rep2

description: Otx2 clone15, Dox-, 48h #2

value: day 2 embryo


title: ES[MC1R(20):tetControl(13)]_day2_Dox- rep1

description: Control clone13, Dox-, 48h #1

value: Dox-

value: Control-48h_rep1; ES[MC1R(20):tetControl(13)]_day2_Dox-_repA; Control clone13, Dox-, 48h #1; 251508710558A3


title: ES[MC1R(20):tetNr2f2(5)]_day2_Dox- rep2

description: Nr2f2 clone5, Dox-, 48h #3

value: mixed


title: ES[MC1R(20):tetWhsc2(18)]_day2_Dox- rep1

description: Whsc2 clone18, Dox-, 48h #1


title: Mononuclear cells Sty19

description: Hybridized to 250K_Sty


title: Mononuclear cells Sty30

description: Hybridized to 250K_Sty


title: ES[MC1R(20):tetKlf4(16)]_day2_Dox- rep2

description: Klf4 clone16, Dox-, 48h #2


title: Mononuclear cells Sty29

description: Hybridized to 250K_Sty


title: Mononuclear cells Sty26

description: Hybridized to 250K_Sty


title: ES[MC1R(20):tetWhsc2(18)]_day2_Dox+ rep2

description: Whsc2 clone18, Dox+, 48h #2

value: Dox+


title: Mononuclear cells Sty24

description: Hybridized to 250K_Sty


title: Mononuclear cells Sty25

description: Hybridized to 250K_Sty


title: Mononuclear cells Sty21

description: Hybridized to 250K_Sty


title: Mononuclear cells Sty20

description: Hybridized to 250K_Sty


title: Mononuclear cells Sty17

description: Hybridized to 250K_Sty


title: Mononuclear cells Sty23

description: Hybridized to 250K_Sty


title: ES[MC1R(20):tetSox2(3)]_day2_Dox- rep1

description: Sox2 clone3, Dox-, 48h #1


title: ES[MC1R(20):tetSox2(3)]_day2_Dox+ rep1

description: Sox2 clone3, Dox+, 48h #1


title: Mononuclear cells Sty16

description: Hybridized to 250K_Sty


title: Mononuclear cells Sty22

description: Hybridized to 250K_Sty


title: ES[MC1R(20):tetPou5f1(18)]_day2_Dox- rep1

description: Pou5f1 clone18, Dox-, 48h #1


title: ES[MC1R(20):tetPou5f1(18)]_day2_Dox- rep2

description: Pou5f1 clone18, Dox-, 48h #2


title: ES[MC1R(20):tetPou5f1(18)]_day2_Dox+ rep2

description: Pou5f1 clone18, Dox+, 48h #2


title: Mononuclear cells Sty15

description: Hybridized to 250K_Sty


title: ES[MC1R(20):tetPou5f1(18)]_day2_Dox+ rep1

description: Pou5f1 clone18, Dox+, 48h #1


title: Mononuclear cells Sty18

description: Hybridized to 250K_Sty


title: Mononuclear cells Sty10

description: Hybridized to 250K_Sty


title: Mononuclear cells Sty12

description: Hybridized to 250K_Sty


title: ES[MC1R(20):tetT(21)]_day2_Dox- rep2

description: Brachyury (T) clone21, Dox-, 48h #2


title: Mononuclear cells Sty27

description: Hybridized to 250K_Sty


title: ES[MC1R(20):tetT(21)]_day2_Dox- rep1

description: Brachyury (T) clone21, Dox-, 48h #1


title: ES[MC1R(20):tetT(21)]_day2_Dox+ rep2

description: Brachyury (T) clone21, Dox+, 48h #2


title: ES[MC1R(20):tetT(21)]_day2_Dox+ rep1

description: Brachyury (T) clone21, Dox+, 48h #1


title: ES[MC1R(20):tetStat3(15)]_day2_Dox- rep1

description: Stat3 clone15, Dox-, 48h #1


title: ES[MC1R(20):tetStat3(15)]_day2_Dox- rep2

description: Stat3 clone15, Dox-, 48h #3


title: Mononuclear cells Sty13

description: Hybridized to 250K_Sty


title: ES[MC1R(20):tetSox2(3)]_day2_Dox- rep2

description: Sox2 clone3, Dox-, 48h #2


title: ES[MC1R(20):tetStat3(15)]_day2_Dox+ rep2

description: Stat3 clone15, Dox+, 48h #3


title: Mononuclear cells Sty8

description: Hybridized to 250K_Sty


title: ES[MC1R(20):tetSox2(3)]_day2_Dox+ rep2

description: Sox2 clone3, Dox+, 48h #2


title: Mononuclear cells Sty9

description: Hybridized to 250K_Sty


title: Mononuclear cells Sty7

description: Hybridized to 250K_Sty


title: ES[MC1R(20):tetStat3(15)]_day2_Dox+ rep1

description: Stat3 clone15, Dox+, 48h #1


title: Mononuclear cells Sty6

description: Hybridized to 250K_Sty


title: ES[MC1R(20):tetAes(24)]_day2_Dox- rep2

description: Aes clone24, Dox-, 48h #3


title: ES[MC1R(20):tetAes(24)]_day2_Dox+ rep2

description: Aes clone24, Dox+, 48h #3


title: Granulocytes UPN88

description: Hybridized to 250K_Sty

value: granulocytes

value: essential thrombocythemia


title: ES[MC1R(20):tetAes(24)]_day2_Dox+ rep1

description: Aes clone24, Dox+, 48h #1

value: Embryonic Stem Cells


title: Mononuclear cells Sty1

description: Hybridized to 250K_Sty


title: ES[MC1R(20):tetAes(24)]_day2_Dox- rep1

description: Aes clone24, Dox-, 48h #2


title: Mononuclear cells Sty4

description: Hybridized to 250K_Sty


title: Granulocytes UPN89

description: Hybridized to 250K_Sty


title: ES[MC1R(20):tetDppa5(7)]_day2_Dox+ rep1

description: Dppa5 clone7, Dox+, 48h #1


title: Mononuclear cells Sty3

description: Hybridized to 250K_Sty


title: ES[MC1R(20):tetDppa5(7)]_day2_Dox+ rep2

description: Dppa5 clone7, Dox+, 48h #3


title: Mononuclear cells Sty2

description: Hybridized to 250K_Sty


title: Granulocytes UPN87

description: Hybridized to 250K_Sty


title: ES[MC1R(20):tetDppa5(7)]_day2_Dox- rep1

description: Dppa5 clone7, Dox-, 48h #2


title: Granulocytes UPN86

description: Hybridized to 250K_Sty


title: Granulocytes UPN82

description: Hybridized to 250K_Sty


title: ES[MC1R(20):tetCbx8(9)]_day2_Dox- rep2

description: Cbx8 clone9, Dox-, 48h #3


title: ES[MC1R(20):tetCbx8(9)]_day2_Dox- rep1

description: Cbx8 clone9, Dox-, 48h #2


title: Granulocytes UPN81

description: Hybridized to 250K_Sty


title: Granulocytes UPN83

description: Hybridized to 250K_Sty


title: ES[MC1R(20):tetCbx8(9)]_day2_Dox+ rep1

description: Cbx8 clone9, Dox+, 48h #1


title: ES[MC1R(20):tetCbx8(9)]_day2_Dox+ rep2

description: Cbx8 clone9, Dox+, 48h #2


title: Granulocytes UPN80

description: Hybridized to 250K_Sty


title: Granulocytes UPN79

description: Hybridized to 250K_Sty

value: polycythemia vera


title: ES[MC1R(20):tetEsx1(16)]_day2_Dox- rep1

description: Esx1 clone16, Dox-, 48h #2

value: male


title: ES[MC1R(20):tetEsx1(16)]_day2_Dox- rep2

description: Esx1 clone16, Dox-, 48h #3


title: Mononuclear cells Sty11

description: Hybridized to 250K_Sty


title: Granulocytes UPN76

description: Hybridized to 250K_Sty


title: ES[MC1R(20):tetSuz12(9)]_day2_Dox- rep2

description: Suz12 clone9, Dox-, 48h #3


title: Granulocytes UPN85

description: Hybridized to 250K_Sty


title: ES[MC1R(20):tetSuz12(9)]_day2_Dox+ rep2

description: Suz12 clone9, Dox+, 48h #3


title: ES[MC1R(20):tetMycn(44)]_day2_Dox+ rep2

description: Mycn clone44, Dox+, 48h #3


title: ES[MC1R(20):tetMycn(44)]_day2_Dox- rep1

description: Mycn clone44, Dox-, 48h #2


title: ES[MC1R(20):tetEsx1(16)]_day2_Dox+ rep1

description: Esx1 clone16, Dox+, 48h #2


title: Granulocytes UPN84

description: Hybridized to 250K_Sty


title: ES[MC1R(20):tetDppa5(7)]_day2_Dox- rep2

description: Dppa5 clone7, Dox-, 48h #3


title: ES[MC1R(20):tetMycn(44)]_day2_Dox+ rep1

description: Mycn clone44, Dox+, 48h #2


title: Granulocytes UPN73

description: Hybridized to 250K_Sty


title: Granulocytes UPN77

description: Hybridized to 250K_Sty


title: ES[MC1R(20):tetEed(36)]_day2_Dox- rep1

description: Eed clone36, Dox-, 48h #2


title: ES[MC1R(20):tetMyc(16)]_day2_Dox- rep2

description: Myc clone16, Dox-, 48h #3


title: ES[MC1R(20):tetEed(36)]_day2_Dox+ rep1

description: Eed clone36, Dox+, 48h #2


title: ES[MC1R(20):tetEed(36)]_day2_Dox+ rep2

description: Eed clone36, Dox+, 48h #3


title: ES[MC1R(20):tetMyc(16)]_day2_Dox+ rep2

description: Myc clone16, Dox+, 48h #2


title: ES[MC1R(20):tetMyc(16)]_day2_Dox- rep1

description: Myc clone16, Dox-, 48h #2


title: Granulocytes UPN75

description: Hybridized to 250K_Sty


title: ES[MC1R(20):tetMyc(16)]_day2_Dox+ rep1

description: Myc clone16, Dox+, 48h #1


title: Granulocytes UPN72

description: Hybridized to 250K_Sty


title: ES[MC1R(20):tetAtf3(5)]_day2_Dox- rep2

description: Atf3 clone5, Dox-, 48h #2


title: ES[MC1R(20):tetAtf3(5)]_day2_Dox- rep1

description: Atf3 clone5, Dox-, 48h #1


title: ES[MC1R(20):tetNr5a2(7)]_day2_Dox+ rep1

description: Nr5a2 clone7, Dox+, 48h #2


title: ES[MC1R(20):tetAtf3(5)]_day2_Dox+ rep1

description: Atf3 clone5, Dox+, 48h #1


title: ES[MC1R(20):tetMybl2(6)]_day2_Dox+ rep1

description: Mybl2 clone6, Dox+, 48h #1


title: Mononuclear cells Sty14

description: Hybridized to 250K_Sty


title: Granulocytes UPN70

description: Hybridized to 250K_Sty


title: Granulocytes UPN78

description: Hybridized to 250K_Sty


title: ES[MC1R(20):tetNr5a2(7)]_day2_Dox+ rep2

description: Nr5a2 clone7, Dox+, 48h #3


title: ES[MC1R(20):tetMsc(24)]_day2_Dox+ rep1

description: Msc clone24, Dox+, 48h #1


title: ES[MC1R(20):tetAtf3(5)]_day2_Dox+ rep2

description: Atf3 clone5, Dox+, 48h #2


title: Granulocytes UPN71

description: Hybridized to 250K_Sty


title: ES[MC1R(20):tetMsc(24)]_day2_Dox+ rep2

description: Msc clone24, Dox+, 48h #2


title: ES[MC1R(20):tetNr0b1(15)]_day2_Dox+ rep1

description: Nr0b1  clone15, Dox+, 48h #2


title: Dermal cells UPN23

description: Hybridized to 250K_Sty

source_name: skin biopsy

value: dermal cells

value: germline control


title: Granulocytes UPN23

description: Hybridized to 250K_Sty


title: ES[MC1R(20):tetTcea3(22)]_day2_Dox- rep1

description: Tcea3 clone22, Dox-, 48h #2


title: ES[MC1R(20):tetTcea3(22)]_day2_Dox- rep2

description: Tcea3 clone22, Dox-, 48h #3


title: ES[MC1R(20):tetTcea3(22)]_day2_Dox+ rep2

description: Tcea3 clone22, Dox+, 48h #3


title: ES[MC1R(20):tetTcea3(22)]_day2_Dox+ rep1

description: Tcea3 clone22, Dox+, 48h #1


title: Mononuclear cells Sty5

description: Hybridized to 250K_Sty


title: ES[MC1R(20):tetTuba1a(12)]_day2_Dox+ rep1

description: Tuba1a clone12, Dox+, 48h #1


title: ES[MC1R(20):tetEsx1(16)]_day2_Dox+ rep2

description: Esx1 clone16, Dox+, 48h #3


title: ES[MC1R(20):tetEed(36)]_day2_Dox- rep2

description: Eed clone36, Dox-, 48h #3


title: ES[MC1R(20):tetCtnnb1(20)]_day2_Dox- rep2

description: Ctnnb1 clone20, Dox-, 48h #3


title: ES[MC1R(20):tetCtnnb1(20)]_day2_Dox+ rep1

description: Ctnnb1 clone20, Dox+, 48h #2


title: ES[MC1R(20):tetCtnnb1(20)]_day2_Dox- rep1

description: Ctnnb1 clone20, Dox-, 48h #2


title: ES[MC1R(20):tetCtnnb1(20)]_day2_Dox+ rep2

description: Ctnnb1 clone20, Dox+, 48h #3


title: Granulocytes UPN74

description: Hybridized to 250K_Sty


title: Heart left ventricle dnCREB-PM replicate 1

status: Public on Aug 10 2009

city: Charlottesville

first: Yong

last: Huang

state: VA

address: 1340 Jefferson Park Ave

department: Medicine

institute: University of Viginia

description: Mouse, male

hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Mouse320_2. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.

scan_protocol: GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.

data_processing: Normalized using GCRMA

label: biotin

source_name: Left ventricle

label_protocol: Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 6 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).

growth_protocol: standard conditions (12h light-dark cycle, 25-27ºC, ~40% humidity)

extract_protocol: Trizol extraction of total RNA was performed according to the manufacturer's instructions.

treatment_protocol: 20mg/kg 1.9µm particulate matter, lung harvest after 36 hour

tag: age

value: 20 week

tag: tissue

value: heart left ventricle

tag: genotype

value: dominant negative CREB1 driven by cardiomyocyte-specific myosin heavy chain-? promoter


title: Heart left ventricle dnCREB-PM replicate 2

description: Mouse, male


title: Heart left ventricle WT-PM replicate 3

description: Mouse, male

value: Wildtype


title: Heart left ventricle dnCREB-PBS replicate 1

description: Mouse, male

treatment_protocol: PBS


title: Heart left ventricle dnCREB-PBS replicate 3

description: Mouse, male


title: Heart left ventricle WT-PM replicate 2

description: Mouse, male


title: Lung dnCREB-PM replicate 3

description: Mouse, male

source_name: Lung

value: lung

value: dominant negative CREB1 driven by cardiomyocyte-specific myosin heavy chain-alpha promoter


title: Heart left ventricle dnCREB-PBS replicate 2

description: Mouse, male


title: Heart left ventricle WT-PM replicate 1

description: Mouse, male


title: Lung dnCREB-PM replicate 1

description: Mouse, male


title: Heart left ventricle WT-PBS replicate 1

description: Mouse, male

value: Wild type


title: Heart left ventricle dnCREB-PM replicate 3

description: Mouse, male


title: Heart left ventricle WT-PBS replicate 3

description: Mouse, male


title: Heart left ventricle WT-PBS replicate 2

description: Mouse, male


title: Lung dnCREB-PM replicate 2

description: Mouse, male


title: Lung dnCREB-PBS replicate 3

description: Mouse, male


title: Lung WT-PM replicate 3

description: Mouse, male


title: Lung dnCREB-PBS replicate 1

description: Mouse, male


title: Lung WT-PM replicate 1

description: Mouse, male


title: tumor 20

status: Public on Jun 19 2009

city: New York

first: Jiun

last: Kang

state: NY

address: 1130 St. Nicholas Avenue

department: Pathology

institute: Columbia University

hyb_protocol: The pellet was resuspended in 40 mL of a hybridization solution containing 50% formamide, 10% dextran sulfate, 2X saline sodium citrate, 4% sodium dodecyl sulfate, and 200 mg yeast tRNA. The hybridization solution was denatured for 10 minutes at 72C and incubated for 1 hour at 37C to allow blocking of repetitive sequences. Hybridizations were performed in slide chambers for 48 hours at 37C.

scan_protocol: After post-hybridization washes, arrays were rinsed, spun dry, scanned into two 16-bit TIFF image files using a GenePix4200A two-color fluorescent scanner, and signal was quantified using GenePix software (Axon Instruments).

data_processing: Log2-transformed fluorescence ratios were calculated from background-subtracted median intensity values, and these ratios were used for normalization using intensity normalization methods. To adjust for effects due to variation between the red and green dyes, LOWESS normalization was applied. Then, the ratio of the red/ green channel of each clone was calculated and log2 transformed. Spot quality criteria were set as foreground to background greater than 3.0 and standard deviation of triplicates less than 0.2. The breakpoint detection and status assignment of genomic regions was performed using GLAD software.

source_name: genomic DNA

label_protocol: Genomic DNA was labeled with the Bioprime DNA Labeling System (Invitrogen, Carlsbad, CA) as described by the manufacturer.

extract_protocol: The genomic DNA was extracted using a genomic DNA purification kit (Promega, Madison, WI).

tag: stage

value: iib

tag: sample

value: patient tumor DNA

value: human normal DNA (Promega)


title: Lung WT-PBS replicate 2

description: Mouse, male


title: Lung WT-PBS replicate 1

description: Mouse, male


title: Lung WT-PBS replicate 3

description: Mouse, male


title: Lung WT-PM replicate 2

description: Mouse, male


title: Lung dnCREB-PBS replicate 2

description: Mouse, male


title: tumor 11

value: female

value: ib


title: tumor 31

value: ia


title: tumor 36


title: tumor 7


title: tumor 28

value: iiia


title: tumor 21

value: male


title: ES[MC1R(20):tetSuz12(9)]_day2_Dox+ rep1

description: Suz12 clone9, Dox+, 48h #1

value: Embryonic Stem Cells

value: day 2 embryo

value: Dox+

value: mixed


title: ES[MC1R(20):tetCdx2(6)]_day2_Dox+ rep1

description: Cdx2 clone6, Dox+, 48h #1


title: MCL016_Mapping250K_Nsp

status: Public on May 01 2009

city: Tokyo

first: Motohiro

last: Kato

address: 7-3-1, Hongo, Bunkyo-ku

country: Japan

institute: University of Tokyo

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MCL016_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.

hyb_protocol: Affymetrix standard protocol

scan_protocol: Affymetrix standard protocol

data_processing: After appropriate normalization of mean array intensities, signal ratios between tumours and anonymous normal references were calculated in an allele-specific manner, and allele-specific copy numbers were inferred from the observed signal ratios based on the hidden Markov model using CNAG/AsCNAR 3.0 software (http://www.genome.umin.jp).

source_name: lymphoma primary specimen

label_protocol: Affymetrix standard protocol

extract_protocol: standard DNA extraction using PUREGENE DNA extracting kit (Gentra, USA)

tag: disease state

value: non-Hodgkin's lymphoma (NHL), Primary


title: MCL024_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MCL024_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MCL018_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MCL018_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MCL026_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MCL026_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: FL039_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
FL039_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MCL031_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MCL031_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MCL021_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MCL021_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MCL015_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MCL015_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MCL022_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MCL022_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MCL020_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MCL020_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MCL014_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MCL014_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MCL009_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MCL009_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: KMH2_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
KMH2_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.

source_name: lymphoma derived cell line

value: lymphoma derived cell line


title: MCL027_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MCL027_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MCL019_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MCL019_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MCL011_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MCL011_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MCL007_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MCL007_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MCL028_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MCL028_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MCL017_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MCL017_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MCL029_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MCL029_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MCL010_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MCL010_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MCL006_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MCL006_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MCL013_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MCL013_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MCL025_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MCL025_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: L540_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
L540_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MCL008_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MCL008_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MCL030_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MCL030_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL018_Mapping50K_Hind240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL018_Mapping50K_Hind240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: HDLM2_Mapping50K_Hind240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
HDLM2_Mapping50K_Hind240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL050_Mapping50K_Hind240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL050_Mapping50K_Hind240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL054_Mapping50K_Hind240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL054_Mapping50K_Hind240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: FL045_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
FL045_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL056_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL056_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL062_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL062_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL057_Mapping50K_Hind240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL057_Mapping50K_Hind240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL042_Mapping50K_Hind240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL042_Mapping50K_Hind240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: FL051_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
FL051_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL046_Mapping50K_Hind240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL046_Mapping50K_Hind240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL015_Mapping50K_Hind240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL015_Mapping50K_Hind240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL059_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL059_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL058_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL058_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL052_Mapping50K_Hind240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL052_Mapping50K_Hind240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: FL048_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
FL048_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MCL037_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MCL037_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MCL035_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MCL035_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MCL032_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MCL032_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MCL012_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MCL012_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: FL044_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
FL044_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: FL047_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
FL047_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: FL046_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
FL046_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MCL036_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MCL036_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MCL034_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MCL034_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL055_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL055_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL048_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL048_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL049_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL049_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL053_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL053_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MCL005_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MCL005_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MCL003_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MCL003_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL051_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL051_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MALT004_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MALT004_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MCL033_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MCL033_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MCL004_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MCL004_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MCL002_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MCL002_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MCL001_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MCL001_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MCL023_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MCL023_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MALT050_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MALT050_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MALT049_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MALT049_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL047_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL047_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: FL043_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
FL043_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MALT003_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MALT003_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MALT039_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MALT039_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL043_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL043_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL045_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL045_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL044_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL044_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: FL042_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
FL042_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MALT002_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MALT002_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL040_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL040_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL037_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL037_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: FL041_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
FL041_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL039_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL039_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL036_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL036_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MALT048_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MALT048_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL028_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL028_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: FL040_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
FL040_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: FL038_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
FL038_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL035_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL035_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MALT047_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MALT047_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL034_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL034_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MALT044_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MALT044_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL033_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL033_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MALT043_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MALT043_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MALT037_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MALT037_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: FL037_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
FL037_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL038_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL038_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MALT045_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MALT045_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MALT046_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MALT046_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: FL026_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
FL026_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: FL028_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
FL028_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: FL033_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
FL033_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: FL027_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
FL027_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL030_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL030_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: FL029_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
FL029_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL024_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL024_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL012_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL012_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL020_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL020_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL016_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL016_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL019_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL019_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MALT038_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MALT038_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MALT040_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MALT040_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MALT036_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MALT036_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: FL021_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
FL021_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL017_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL017_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MALT013_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MALT013_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL013_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL013_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MALT001_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MALT001_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MALT035_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MALT035_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL014_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL014_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MALT081_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MALT081_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MALT080_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MALT080_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MALT052_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MALT052_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: FL020_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
FL020_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MALT034_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MALT034_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MALT012_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MALT012_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MALT054_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MALT054_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL041_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL041_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MALT041_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MALT041_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MALT062_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MALT062_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MALT079_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MALT079_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: FL018_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
FL018_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: DLBCL003_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
DLBCL003_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: FL014_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
FL014_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MALT077_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MALT077_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MALT078_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MALT078_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: FL019_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
FL019_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: FL015_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
FL015_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: FL013_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
FL013_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MALT076_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MALT076_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: FL017_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
FL017_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MALT042_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MALT042_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: FL016_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
FL016_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: MALT073_Mapping50K_Xba240

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
MALT073_Mapping50K_Xba240
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.


title: FL012_Mapping250K_Nsp

description:
We have used anonymous normal references (own-lab-generated) for SNP array analysis.
FL012_Mapping250K_Nsp
Clinical information of primary lymphoma samples subjected to SNP arrays analysis can be found in Supplementary Table 1 of the associated publication.